Who
Edward A. Pesicka
Director
Company insider
Files Form 4 as: Director, Fortrea Holdings; President & CEO, Accendra Health; Senior Vice President, Thermo Fisher Scientific.
In numbers
- Trades disclosed
- 175
- Buys
- 0
- Sells
- 28
- Bought
- $0
- Sold
- $81.6M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 10 Jul 2008
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —38,817 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —38,817 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —12,852 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —38,817 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —12,852 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —38,817 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | ACH Accendra HealthDistributors & Wholesale | SEC FORM 4 Code F | $54K17,692 at $3.04 | filing |
| 15 May 2026filed 19 May 2026 | ACH Accendra HealthDistributors & Wholesale | SEC FORM 4 Code F | $54K17,692 at $3.04 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ACH Accendra HealthDistributors & Wholesale | SEC FORM 4 Code F | $120K58,945 at $2.03 | filing |
| 20 Mar 2026filed 24 Mar 2026 | ACH Accendra HealthDistributors & Wholesale | SEC FORM 4 Code F | $120K58,945 at $2.03 | filing |
| 10 Jun 2025filed 12 Jun 2025 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —38,817 at $0.00 | filing |
| 15 May 2025filed 16 May 2025 | ACH Accendra HealthDistributors & Wholesale | SEC FORM 4 Code F | $246K35,208 at $7.00 | filing |
| 14 May 2025filed 16 May 2025 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —7,282 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —7,282 at $0.00 | filing |
| 20 Mar 2025filed 24 Mar 2025 | ACH Accendra HealthDistributors & Wholesale | SEC FORM 4 Code F | $148K14,715 at $10.09 | filing |
| 3 Mar 2025filed 5 Mar 2025 | ACH Accendra HealthDistributors & Wholesale | SEC FORM 4 Code A | —445,279 at $0.00 | filing |
| 18 Jul 2024filed 19 Jul 2024 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,354 at $0.00 | filing |
| 18 Jul 2024filed 19 Jul 2024 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —6,354 at $0.00 | filing |
| 15 May 2024filed 16 May 2024 | ACH Accendra HealthDistributors & Wholesale | SEC FORM 4 Code F | $902K45,604 at $19.78 | filing |
| 14 May 2024filed 16 May 2024 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —7,282 at $0.00 | filing |
News
Thermo Fisher Scientific Outperforms on Strong Results and Life Sciences RecoveryTMO · insidermonkey.com · 16 Oct 2026Thermo Fisher Scientific Inc. $TMO Shares Acquired by Artemis Investment Management LLPTMO · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Edward A. Pesicka; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.